Associations of toenail arsenic, cadmium, mercury, manganese, and lead with blood pressure in the Normative aging study

Environmental Health Perspectives

Volumn 120, Issue 1, 2012, Pages 98-104

  Mordukhovich, Irina ^a   Wright, Robert O ^b,c   Hu, Howard ^d   Amarasiriwardena, Chitra ^c   Baccarelli, Andrea ^b,e   Litonjua, Augusto ^c   Sparrow, David ^f   Vokonas, Pantel ^f   Schwartz, Joel ^b,c  

^a IL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MILAN   (Italy)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Blood pressure; Cadmium; Epidemiology; Lead; Manganese; Mercury; Metals

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARSENIC; CADMIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEAD; MANGANESE; MERCURY;

AGED; AGING; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DRUG USE; FISH; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LONG TERM EXPOSURE; MALE; NAIL; PRIORITY JOURNAL; PULSE PRESSURE; SHELLFISH; SMOKING; SYSTOLIC BLOOD PRESSURE; TOE; TOE NAIL; UNITED STATES;

AGED; AGING; ARSENIC; BLOOD PRESSURE; BOSTON; CADMIUM; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL POLLUTANTS; HUMANS; HYPERTENSION; LEAD; MALE; MANGANESE; MERCURY; METALS, HEAVY; NAILS;

EID: 84855215438     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002805     Document Type: Article

References (72)

1. Adair BM, Hudgens EE, Schmitt MT, Calderon RL, Thomas DJ. 2006. Total arsenic concentrations in toenails quantified by two techniques provide a useful biomarker of chronic arsenic exposure in drinking water. Environ Res 101(2):213-220.
2. Anwar M. 2005. Arsenic, cadmium, and lead levels in hair and toenail samples in Pakistan. Environ Sci 12:71-86.
3. Appel LJ, Miller ER, Seidler AJ, Whelton PK. 1993. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 153(12):1429-1438.
4. ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological Profile for Arsenic CAS# 7440-38-2. Atlanta, GA:ATSDR.
5. Barbosa F Jr, Tanus-Santos JE, Gerlach RJ, Parsons PJ. 2005. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 113:1669-1674.
6. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. 2004. Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol 160(7):679-687.
7. Bell B, Rose C, Damon A. 1972. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 3:5-17.
8. Benbrahim-Tallaa L, Waalkes MP. 2008. Inorganic arsenic and human prostate cancer. Environ Health Perspect 116:158-164.
9. Brodkin E, Copes R, Mattman A, Kennedy J, Kling R, Yassi A. 2007. Lead and mercury exposures: interpretation and action. CMAJ 176(1):59-63.
10. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, et al. 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25(1):53-60.
11. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, Parvez F, et al. 2007. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol 165(5):541-552.
12. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. 2001. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol 153(2):164-171.
13. Cui JS, Hopper JL, Harrap SB. 2003. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 41(2):207-210.
14. Dastgiri S, Mosaferi M, Fizi MA, Olfati N, Zolali S, Pouladi N, et al. 2010. Arsenic exposure, dermatological lesions, hypertension, and chromosomal abnormalities among people in a rural community of northwest Iran. J Health Popul Nutr 28(1):14-22.
15. Dickinson BD, Havas S, Council on Science and Public Health, American Medical Association. 2007. Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health. Arch Intern Med 167(14):1460-1468.
16. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. 1994. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 16(2):184-209.
17. Garland M, Morris JS, Rossner BA, Stampfer MJ, Spate VL, Baskett CJ, et al. 1993. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493-497.
18. Gonzalez-Muñoz MJ, Sanchez-Muniz FJ, Rodenas S, Sevillano MI, Larrea Marin MT, Bastida S. 2010. Differences in metal and metalloid content in the hair of normo- and hypertensive postmenopausal women. Hypertens Res 33(3):219-224.
19. Henson MC, Chedrese PJ. 2004. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med 229(5):383-392.
20. Hogan JW, Lancaster T. 2004. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies. Stat Methods Med Res 13(1):17-48.
21. Houston MC. 2007. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med 13(2):S128-S133.
22. Houtman JP. 1996. Trace elements and cardiovascular diseases. J Cardiovasc Risk 3(1):18-25.
23. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, et al. 1996. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275(15):1171-1176.
24. Hu H, Shih R, Rothenberg S, Schwartz BS. 2007. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115:455-462.
25. Jiang YM, Lu JP, Huang ZB, Lu ZG, Huang JL, Huang HH. 2002. Effects of manganese exposure on cardiovascular functions of male workers. Ind Health Occup Dis 28:65-67.
26. Jiang Y, Zheng W. 2005. Cardiovascular toxicities upon manganese exposure. Cardiovasc Toxicol 5(4):345-354.
27. Johansson N, Basun H, Winblad B, Nordberg M. 2002. Relationship between mercury concentration in blood, cognitive performance, and blood pressure, in an elderly urban population. Biometals 15(2):189-195.
28. Joshi A, Douglass CW, Kim HD, Joshipura KJ, Park MC, Rimm EB, et al. 2003. The relationship between amalgam restorations and mercury levels in male dentists and nondental health professionals. J Public Health Dent 63(1):52-60.
29. Kagamimori S, Watanabe M, Nakagawa H, Okumura Y, Kawano S. 1986. Case-control study on cardiovascular function in females with a history of heavy exposure to cadmium. Bull Environ Contam Toxicol 36(4):484-490.
30. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK. 2001. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 153(6):559-565.
31. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V, et al. 2000. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 152(1):84-90.
32. Kayama F, Yoshida T, Elwell MR, Luster MI. 1995. Cadmium-induced renal damage and proinflammatory cytokines: possible role of IL-6 in tubular epithelial cell regeneration. Toxicol Appl Pharmacol 134(1):26-34.
33. Kwok RK, Mendola P, Liu ZY, Savitz DA, Heiss G, Ling HL, et al. 2007. Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol Appl Pharmacol 222(3):337-343.
34. Kwong RC, Karagas MR, Kelsey KT, Mason RA, Tanyos SA, Schned AR, et al. 2010. Arsenic exposure predicts bladder cancer survival in a US population. World J Urol 28(4):487-492.
35. MacIntosh DL, Williams PL, Hunter DJ, Sampson LA, Morris SC, Willett WC, et al. 1997. Evaluation of a food frequency questionnaire-food composition approach for estimating dietary intake of inorganic arsenic and methylmercury. Cancer Epidemiol Biomarkers Prev 6:1043-1050.
36. Misselwitz B, Muhler A, Weinmann HJ. 1995. A toxicologic risk for using manganese complexes? A literature survey of existing data through several medical specialties. Invest Radiol 30(10):611-620.
37. Mortada WI, Sobh MA, el-Defrawy MM, Farahat SE. 2002. Reference intervals of cadmium, lead, and mercury in blood, urine, hair, and nails among residents in Mansoura city, Nile delta, Egypt. Environ Res 90:104-110.
38. MWRA (Massachusetts Water Resources Authority). 2011. Monthly Water Quality Test Results. Available: http://www.mwra.state.ma.us/monthly/wqupdate/qual3wq.htm [accessed 10 March 2010].
39. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. 2007. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect 115:472-482.
40. Pedersen EB, Jorgensen ME, Pedersen MB, Siggaard C, Sorensen TB, Mulvad G, et al. 2005. Relationship between mercury in blood and 24-h ambulatory blood pressure in Greenlanders and Danes. Am J Hypertens 18(5 pt 1):612-618.
41. Perlstein T, Weuve J, Schwartz J, Sparrow D, Wright R, Litonjua A, et al. 2007. Cumulative community-level lead exposure and pulse pressure: the Normative Aging Study. Environ Health Perspect 115:1696-1700.
42. Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H, et al. 2000. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 28(7):1137-1142.
43. Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW. 2002. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288-296.
44. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. 1999. Hypertension and arsenic exposure in Bangladesh. Hypertension 33(1):74-78.
45. Rees JR, Sturup S, Chen C, Folt C, Karagas MR. 2007. Toenail mercury and dietary fish consumption. J Expo Sci Environ Epidemiol 17:25-30.
46. Rosin A. 2009. The long-term consequences of exposure to lead. Isr Med Assoc J 11(11):689-694.
47. Rubba P. 2007. Effects of atorvastatin on the different phases of atherogenesis. Drugs 67 (suppl 1):17-27.
48. Santamaria AB. 2008. Manganese exposure, essentiality and toxicity. Indian J Med Res 128(4):484-500.
49. Satarug S, Moore MR. 2004. Adverse effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112:1099-1103.
50. Satarug S, Nishijo M, Lasker JM, Edwards RJ, Moore MR. 2006. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases? Tohoku J Exp Med 208(3):179-202.
51. Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR. 2005. Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett 157(1):57-68.
52. Slotnick MJ, Meliker JR, AvRuskin GA, Ghosh D, Nriagu JO. 2007. Toenails as a biomarker of inorganic arsenic intake from drinking water and foods. J Toxicol Environ Health A 70(2):148-158.
53. Slotnick MJ, Nriagu JO. 2006. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res 102:125-139.
54. Slotnick MJ, Nriagu JO, Johnson MM, Linder AM, Savoie KL, Jamil HJ, et al. 2005. Profiles of trace elements in toenails of Arab-Americans in the Detroit area, Michigan. Biol Trace Elem Res 107(2):113-126.
55. Staessen J, Amery A, Bernard A, Bruaux P, Buchet JP, Bulpitt CJ, et al. 1991. Blood pressure, the prevalence of cardiovascular diseases, and exposure to cadmium: a population study. Am J Epidemiol 134(3):257-267.
56. Staessen JA, Kuznetsova T, Roels HA, Emelianov D, Fagard R. 2000. Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Am J Hypertens 13(2):146-156.
57. Su DM, Li JY, Liu SZ, Guo GX. 1998. Investigation on health in manganese ferroalloy workers. Occup Health Emerg Rescue 16:148-149.
58. Taneja SK, Mandal R. 2007. Mineral factors controlling essential hypertension - a study in the Chandigarh, India population. Biol Trace Elem Res 120(1-3):61-73.
59. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Guallar E. 2008. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect 116:51-56.
60. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. 2005. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 24(19):2911-2935.
61. Tsuji JS, Van Kerkhove MD, Kaetzel RS, Scrafford CG, Mink PJ, Barraj LM, et al. 2005. Evaluation of exposure to arsenic in residential soil. Environ Health Perspect 113:1735-1740.
62. Tubek S, Tubek S. 2008. The content of elements in rainwater and its relation to the frequency of hospitalization for arterial hypertension, chronic obstructive pulmonary disease, and psoriasis in Opole Voivodship, Poland during 2000-2002. Biol Trace Elem Res 123(1-3):270-276.
63. Valera B, Dewailly É, Poirier P. 2009. Environmental mercury exposure and blood pressure among Nunavik Inuit adults. Hypertension 54(5):981-986
64. Valko M, Morris H, Cronin MT. 2005. Metals, toxicity and oxidative stress. Curr Med Chem 12(10):1161-1208.
65. Varoni MV, Palomba D, Gianorso S, Anania V. 2003. Cadmium as an environmental factor of hypertension in animals: new perspectives on mechanisms. Vet Res Commun 27(suppl 1):807-810.
66. Vinceti M, Venturelli M, Sighinolfi C, Trerotoli P, Bonvicini F, Ferrari A, et al. 2007. Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ 373(1):77-81.
67. Wakita Y. 1987. Hypertension induced by methyl mercury in rats. Toxicol Appl Pharmacol 89(1):144-147.
68. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. 1985. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65.
69. Wu MM, Chiou HY, Ho IC, Chen CJ, Lee TC. 2003. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 111:1429-1438.
70. Yang HT, Chou HJ, Han BC, Huang SY. 2007. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats. Food Chem Toxicol 45(12):2479-2487.
71. Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh CC, Spiegelman D, et al. 2002. Mercury and risk of coronary heart disease in men. N Engl J Med 347:1755-1760.
72. Zierold KM, Knobeloch L, Anderson H. 2004. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health 94(11):1936-1937.